PsyMed Ventures
Overview
Investment syndicate for early-stage psychedelics companies.
Founded
2020
Deals · 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Remepy | Aug 2026Participated | $36 MSeries A | |
Aerska | Oct 2025Participated | $21 MSeed | |
Jimini Health | Nov 2024Participated | $8 MSeed | |
Neurode | Sep 2024Participated | $4 MSeed | |
Ancilia Biosciences | Aug 2024Participated | $4 MOther Equity | |
Remepy | May 2024Participated | $10 MSeed | |
Motif Neurotech | Jan 2024Participated | $19 MSeries A | |
Journey Clinical | Jan 2023Participated | $9 MSeries A | |
Freedom Biosciences | Aug 2022Participated | $11 MSeed | |
Delix Therapeutics | Sep 2021Participated | $70 MSeries A | |
Journey Clinical | Sep 2021Participated | $3 MSeed | |
Remepy | Aug 2026Participated | $36 MSeries A | |
Aerska | Oct 2025Participated | $21 MSeed | |
Jimini Health | Nov 2024Participated | $8 MSeed | |
Neurode | Sep 2024Participated | $4 MSeed | |
Ancilia Biosciences | Aug 2024Participated | $4 MOther Equity | |
Remepy | May 2024Participated | $10 MSeed | |
Motif Neurotech | Jan 2024Participated | $19 MSeries A | |
Journey Clinical | Jan 2023Participated | $9 MSeries A | |
Freedom Biosciences | Aug 2022Participated | $11 MSeed | |
Delix Therapeutics | Sep 2021Participated | $70 MSeries A | |
Journey Clinical | Sep 2021Participated | $3 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 6 |
| Series A | 0 | 4 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '21 | 2 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 1 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 1 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 11 |
| Marketing & Advertising | 1 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 2 |
| $10M-$25M | 4 |
| $25M-$50M | 1 |
| $50M-$100M | 1 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
| Israel | 2 |
| Europe | 1 |
| Australia | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Palo Santo | 3 |
| 97212 Ventures | 2 |
| Dolby Family Ventures | 2 |
| Fifty Years | 2 |
| Fresh Fund | 2 |
| NFX | 2 |
| re.Mind Capital | 2 |
| Satori Neuro | 2 |
| TechAviv | 2 |
| Vine Ventures | 2 |
| Ada Ventures | 1 |
| age1 | 1 |
| AlleyCorp | 1 |
| Apeiron Investment Group | 1 |
| Arboretum Ventures | 1 |
| Arkitekt Ventures | 1 |
| ARTIS Ventures | 1 |
| Backed | 1 |
| Bail Capital | 1 |
| BlueYard Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 11 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Chief of Staff
Founder
Venture Partner
Founder
Co-founder and General Partner